Background: Observational studies have reported conflicting results between parity
Introduction
The incidence of renal cell cancer, the most common type of kidney cancer which represents approximately 85% of all kidney cancers (1), has been steadily increasing in the United States and worldwide (2, 3) . A recent report also suggested that the incidence rate of kidney cancer has increased rapidly in the past thirty years among the adolescents and young adults in Shanghai, China (4).
Cigarette smoking, obesity and hypertension are the most established risk factors for kidney cancer in both genders (1, 5) . Besides, the difference in incidence by gender, a role of hormone-related or reproductive factors in kidney cancer etiology has been hypothesized (1) . Animal studies have demonstrated that estrogens can promote or induce kidney cancer development (6) . Fluctuating sex hormones have also been shown to make nephrons vulnerable to inflammation and oxidative stress (7) .
A recent meta-analysis of epidemiological studies suggested that women who undergo a hysterectomy have an approximate 30% increased relative risk of subsequent kidney cancer (8) , which provided evidence that hormonal and iatrogenic factors might play a role in the etiology of kidney cancer. However, the results of other reproductive factors including parity are conflicting which might be attributed to the limited statistical power to detect those associations. Though previous reviews have focused on this topic (1, 9) , to our knowledge, a comprehensive and quantitative assessment of the association between parity number and kidney cancer risk has not been reported. Therefore, to evaluate the relationship between parity and kidney 7 (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (Figure 1 ). Two articles were excluded because of duplicate reports from the same study population (24, 27) , three articles were excluded because they did not report usable or enough data of risk estimate (20, 29, 30) , and one article was excluded because of the use of mortality data (11) . One study (21) only reported the highest versus lowest category of parity number and was therefore only included in the parity number and does-response analysis. As part of the International study of Landblad et al (21) , Mellemgaard et al (23) reported more information which was included in the analysis of the association between ever parity and kidney cancer risk.
Data abstraction
For each eligible study, two investigators (H-BG and T-TG) independently performed the eligibility evaluation and data abstraction. The disagreements were discussed and resolved by consensus or by involving a third reviewer (Q-JW) for adjudication. Data abstracted from each study were: author list, year of publication, study region and design, study sample size (number of cases and controls or cohort size), range of follow-up for prospective studies, exposure and outcome assessment including ever parity and parity number categories, study-specific adjusted estimates with their 95% CIs for the ever versus never parity and highest versus lowest of parity number, and factors matched by or adjusted for in the design or data analysis. If multiple estimates of the association were available, we abstracted the estimate that adjusted for the most covariates. If no adjusted estimates were presented, we included the crude estimate. If no estimate was presented in a given study, we calculated it and 
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Statistical analysis
The study-specific adjusted RRs were used as the measure of association across studies. Because the absolute risk of kidney cancer is low, we assumed that estimates of ORs from case-control studies and risk, rate or hazard ratios from prospective studies were all valid estimates of the RR and we therefore report all results as the RR for simplicity. For studies that did not use the category with the lowest parity number as the reference (13, 14, 17, 28) , we used the effective count method proposed by Hamling et al (31) to recalculate the RRs. 
Result Study characteristics
Characteristics of the 14 included articles (12-19, 21-23, 25, 26, 28) are shown in Supplementary Table S1 . The included articles, which represent 5389 cases and 651,072 non-cases, were published between 1974 and 2013 and consist of 6 prospective studies (5 cohort studies (12, 14, 15, 17, 18) and one nested case-control study (19) ) and 8 case-control studies (13, 16, 21-23, 25, 26, 28) . Of the 6 prospective studies, four were conducted in the United States (12, 14, 15, 17) , and one each in Canada (18) and Sweden (19) . Cohort sizes ranged from 37,440 (17) to 283,952 (12) , and the number of kidney cancer cases varied from 165 (17) to 1465 (19) .
Of the 8 case-control studies, three were conducted in the United States (13, 22, 26) , two in Italy (16, 25) , one each in Denmark (23) and International cooperation group which covered multiple countries (21) . The number of cases enrolled in these studies ranged from 56 (25) to 608 (21) , and the number of control subjects varied from 227 (22) to 5619 (25) . Control subjects were drawn from the general population in 5 studies (13, (21) (22) (23) 28) , hospitals in 3 studies (16, 25, 26) . The highest parity number varied from 3 (16) to over 6 (21) .
Ever vs. never parity
Six prospective (12, 14, 15, (17) (18) (19) ) and 7 case-control studies (13, 16, 22, 23, 25, 26, 28) investigated the association between ever parity and kidney cancer risk. The summary RR of kidney cancer for the ever vs. nulliparous was 1.23 (95% CI: Figure 3 ). There was no indication of publication bias with Egger's test (P for bias=0.816) or with Begg's test (P for bias=1.000) and no asymmetry was seen in the funnel plots when inspected visually.
In a sensitivity analysis, we sequentially removed one study at a time and re-analyzed the data. The 13 study-specific RRs of the parity number ranged from a low of 1.31 (12) .
Dose-response analysis
Four prospective (15, (17) (18) (19) ) and 7 case-control studies (13, 16, 21, 22, 25, 26, 28) were included in the dose-response analysis. The summary RR per live birth was 1.08 (95% CI: 1.05-1.10), with none of heterogeneity (Q=9.34, P=0.500, I 2 =0%) ( Table 2 and Figure 4 
Subgroup analyses
In subgroup analyses of ever parity and kidney cancer risk, all strata showed positive associations, and there was no evidence of significant heterogeneity between (Table 1 ). In the dose-response analyses of the association between parity number and kidney cancer risk, we also yielded the similar results (Table 2 ). Similar to the previously study (38) , we also performed the subgroup analysis by the primary interest (whether the title or abstract refer to the reproductive factors as their research interest) to focus on whether different existed.
However, the results of the meta-regression hardly support this point and only two studies (26, 28) did not consider the reproductive factors as the primary interest of their research. When stratified by the adjustment for potential confounders, we did not find a significant difference between estimates adjusted and those not adjusted for specific factors (Table 1 and Table 2 ).
Discussion
To our knowledge, this is the first meta-analysis to provide evidence of the association between parity and kidney cancer risk. Findings from this study indicated that ever parity and increased parity number are associated with an increased risk of kidney cancer. Overall, the risk of kidney cancer increased by 23% among populations who ever parity. Furthermore, in the dose-response analysis, the risk of Author Manuscript Published OnlineFirst on October 9, 2013; DOI: 10.1158/1055-9965.EPI-13-0759-T more vulnerable to inflammation or oxidative stress through pregnancy-induced physiologic changes such as increases in maternal blood volume, cardiac output, renal plasma flow, glomerular filtration, kidney size, dilation of the renal pelvis, and excess risk of urinary tract infection (7, 40, 41) . Anatomic change in the kidney during pregnancy might also contribute to the oxidative stress and inflammation of the nephrons (7, 40) . In addition, hormones, either directly or through growth factors, may act as promoters of malignant changes by stimulating renal cell proliferation (42) .
High doses of potent estrogens have been shown to induce renal cancers in the Syrian hamster (43) . The expression of estrogen and progesterone receptors in both normal and malignant renal tissue also suggests that endocrine regulation could directly influence kidney cancer development (44, 45). On the other hand, obesity is a known risk factor for kidney cancer and is associated with pregnancy. Pregnancy-associated weight gain may contribute towards an increased risk of kidney cancer (46, 47).
When we carried out the subgroup analysis by geographic location, significantly positive associations were both observed among Europe and North America.
Considering about the limited included studies of Europe, the interpretation of the result should be cautiously. We found few studies from Asia and the only one study (11) focused on this topic from Taiwan was excluded because of using mortality data.
Compared to the reports from west countries, Chiu et al (11) was the only study to report that increased parity was associated with a tendency for decreased kidney cancer risk, but without statistical significance. Therefore, more Asia studies should focus on this topic even though the incidence of kidney cancer is lower than west Our meta-analysis has several strengths. Although the majority of the included studies showed positive association between parity and kidney cancer risk, not all of them (14, 18, 19, 21) showed statistical significant which could be attributed to the limited statistical power. Our study includes the large sample size of 5,389 cases and 651,072 non-cases. This sample size should have provided sufficient statistical power to detect this putative association. In addition, though the summary results demonstrated little heterogeneity, we also carried out a number of subgroups and sensitivity analyses and the results showed robust. Several limitations must be addressed. First, as a meta-analysis of epidemiological studies, the biases (e.g., recall and selection bias) inherent in the original studies could not be avoided. Cohort studies are less susceptible to bias than case-control studies because, in the prospective design, information on exposures is collected before the diagnosis of the disease. Although the results of the meta-regression found no evidence of significant heterogeneity between subgroups by study design and exposure assessment and the results almost similar in the dose-response analysis (Table 2) , we only yielded the significant results in the prospective studies and the summary association estimates was slightly different in subgroup analyses by exposure assessment (Table 1) . It is possible that the relationships reported by case-control studies may have been overstated due to recall or interviewer bias. Additionally, considering about some recent epidemiological studies provided detailed information of adjustment for confounders, whereas some early studies adjusted for fewer factors, we also Secondly, parity may be associated with several other factors (e.g. higher exposure to obesity (46, 47) , more exposure to hypertension (48, 49) ) which were the established risk factors for kidney cancer. Although the results persisted in all the subgroups and the meta-regression analyses did not show statistical significance, different was still observed among the stratified analyses according to whether confounders had been adjusted for or not. Similar patterns were also observed among the stratified analyses by whether adjusted for all the possible confounders/risk factors or not which might be partly attributed to the limited numbers of studies (Table 1 and 2). Thus, any further studies should report analyses which considered about these important confounders and adjusted or stratified by other risk factors to better be able to rule out residual confounding.
Third, the summary results are combined from studies conducted with different study design in different populations, heterogeneity must be considered. Nevertheless, there was little heterogeneity in the overall, subgroups and sensitivity analyses of this study. On the other hand, publication bias can be a problem in meta-analyses of published studies; however, we found no statistical evidence of publication bias in this meta-analysis by Egger's linear regression and Begg's rank correlation methods, and there did not appear to be asymmetry in the funnel plots when inspected visually.
In conclusion, our meta-analysis provided evidence that ever parity and increased parity number are associated with an increased risk of kidney cancer. Further research, 
